Singular Genomics Systems (OMIC): Operating Profitability

Singular Genomics Systems - graphic logo of issuer OMIC

Singular Genomics Systems (OMIC) generates revenue through the sale of benchtop analyzers and accompanying reagents for DNA diagnostics. Operating profit margins on GURU.Markets show a local peak, where the -3488.50 mark characterizes this parameter. The stability of operating profitability is supported by the diversification of optics suppliers. However, small-batch production of instruments limits the leverage effect, maintaining a high unit cost for the equipment.

OMIC: singulargenomics.com Profitability of Operations 07/04/2022 - 03/01/2025

OMIC (Singular Genomics): analytical breakdowns and indicator data

Fundamental company valuation:OMIC, Singular Genomics Corp
Core merchandise of singulargenomics.com

To identify a fundamental support level for the Singular Genomics Systems (OMIC) business, it is essential to evaluate the effectiveness of its competition with monopolists via the operating profit margin. This chart measures the share of profit from core operations relative to total revenue, reflecting the ability of the open-architecture sequencing systems to generate cash flow before taxes and interest, which determines the long-term sustainability of the asset.

Competitor analysis

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|Operating Profit Rate BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operating Profitability|Bluebird Bio - Operating Profit Rate|IPA (ImmunoPrecise Antibodies Ltd) - Operating Margin|Operating Return on Sales Omega Therapeutics, Inc. OMGA|Operating Profitability Regulus Therapeutics Inc. (RGLS)|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability